Ligand validation:5TBJ

PG6: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5TBJ_PG6_B_505	15%	74%	0.256	0.817	0.51	0.49	-	-	1	0	100%	1
5LGR_PG6_B_502	7%	77%	0.193	0.649	0.51	0.4	-	-	0	0	100%	1
5ISG_PG6_A_507	6%	78%	0.274	0.716	0.52	0.38	-	-	0	0	100%	1
5LGQ_PG6_A_505	3%	76%	0.287	0.6	0.5	0.44	-	-	1	0	100%	1
5K8V_PG6_B_502	2%	79%	0.256	0.544	0.53	0.34	-	-	0	0	100%	1
7FCN_PG6_A_201	82%	84%	0.085	0.938	0.53	0.25	-	-	2	0	100%	0.528
3ON2_PG6_C_201	78%	72%	0.085	0.927	0.5	0.59	-	-	0	0	100%	1
6ZL7_PG6_A_402	77%	81%	0.072	0.96	0.24	0.58	-	-	0	0	72%	0.7222
5FIP_PG6_B_1393	71%	75%	0.094	0.914	0.57	0.4	-	-	3	0	100%	1
6QLA_PG6_A_403	71%	87%	0.089	0.949	0.31	0.37	-	-	0	0	78%	0.3889

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.